Spotting ovarian cancer, before it's too late

December 19, 2012 by Mark Riechers
Credit: Normal (left) and cancerous (right) cells.

(Medical Xpress)—At just 28 percent, the five-year survival rate for women diagnosed with ovarian cancer is much lower than in other cancer cases. And, the disease can easily go unnoticed, making it difficult to find effective treatments. "There are very few symptoms associated with ovarian cancer," says Biomedical Engineering Associate Professor Paul Campagnola. "When it gets detected, it's usually too late."

While his colleagues work to find the most efficient therapies for patients in the later stages of the disease, Campagnola and his students are using more nuanced analysis of tissue imaging to diagnose ovarian and earlier. Understanding what tissue changes preclude the development of certain cancers could help doctors diagnose eariler and give patients a wider window in which to seek treatment. "We're trying to develop a physical and biochemical understanding of the changes that happen as cancer develops," says Campagnola.

The key lies in understanding the (ECM), the tissue made up of collagen and elastin that essentially holds the body together. The ECM supports all organs, including the skin. "It's increasingly recognized that there are changes in the collagen—particularly in the extracellular matrix—that accompany almost all cancers," says Campagnola. "Almost all cancers are epithelial—that's the top layer of cells—but they interact with the tissue below it."

Modeling how cancers can dictate the types and concentration of different collagens in the ECM nearby, Campagnola hopes to identify less common "collagen isoforms" as markers that could be used to screen women at risk for ovarian cancer regularly, improving their odds of an early diagnosis.

Campagnola and his students are developing a combination of optics and imaging techniques that could improve the odds an ovarian has at survival. And they are imaging different mixtures of known collagen types with a variety of techniques to see if they can differentiate between normal and abnormal ECM structure. That, says Campagnola, is key to an accurate diagnosis.

Explore further: Role of known cancer gene in ovarian cancer investigated

Related Stories

Role of known cancer gene in ovarian cancer investigated

February 14, 2012
The role of a known cancer-causing gene in the development of the most lethal type of ovarian cancer is being investigated by researchers from the Walter and Eliza Hall Institute after they were awarded a Cure Cancer Australia ...

Targeted testing offers treatment hope for ovarian cancer patients

May 31, 2011
Women with ovarian cancer could be helped by a new test that identifies the specific type of tumour they have, a conference will hear this week.

Potential for earlier diagnosis of ovarian cancer

January 25, 2012
(Medical Xpress) -- Australian scientists have identified biochemical changes that commonly occur in the DNA of women with ovarian cancer, which may help diagnose the cancer at an earlier stage in the future.

New hybrid imaging device shows promise in spotting hard-to-detect ovarian cancer

September 13, 2011
By combining three previously unrelated imaging tools into one new device, a team of researchers from the University of Connecticut and the University of Southern California has proposed a new way to diagnose early-stage ...

Researchers investigate drug resistant ovarian cancer to improve clinical treatment

August 9, 2012
(Medical Xpress) -- A new study by TCD researchers investigates drug-resistant ovarian cancer cells. The findings which have been recently published in the international publication, PLoS One will increase understanding of ...

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.